Lansoprazole

Product NDC: 50090-6830
11-digit product format: 500906830
Labeler code: 50090
Product ID: 50090-6830_bcea941c-d404-4e4d-9ea9-028efb0355d7
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: lansoprazole
Dosage form: CAPSULE, DELAYED RELEASE
Route: ORAL
Labeler: A-S Medication Solutions
Application: ANDA091269
Marketing category: ANDA
Marketing start: 2010-10-15
Substance: LANSOPRAZOLE
Active strength: 30 mg/1
Pharmacologic classes: Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]
NDC exclude flag: No
Listing certified through: 2026-12-31
Current FDA listing: Yes

openFDA Listing Details

Product ID: 50090-6830_bcea941c-d404-4e4d-9ea9-028efb0355d7
Product type: HUMAN PRESCRIPTION DRUG
Finished product: Yes
Brand name base: Lansoprazole
Generic name: lansoprazole
Dosage form: CAPSULE, DELAYED RELEASE
Route: ORAL
Marketing start: 2010-10-15
Marketing category: ANDA
Application number: ANDA091269
Pharmacologic classes: Inhibition Gastric Acid Secretion [PE]; Proton Pump Inhibitor [EPC]; Proton Pump Inhibitors [MoA]
Listing expiration: 2026-12-31

Ingredient	Strength
LANSOPRAZOLE	30 mg/1

UNII	Preferred term	Registry number	Matched term
0K5C5T2QPG	LANSOPRAZOLE	103577-45-3	LANSOPRAZOLE

Package NDC	11-digit format	Description	Marketing start	Sample	Exclude flag	Status
50090-6830-0	50090683000	90 CAPSULE, DELAYED RELEASE in 1 BOTTLE (50090-6830-0)	2023-11-21	No	No	Current

Title	Manufacturer	Effective date	Type	Version
Lansoprazole	A-S Medication Solutions	2023-11-28	HUMAN PRESCRIPTION DRUG LABEL	16